Label: CESAMET- nabilone capsule

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: CII
  • Marketing Status: New Drug Application

Drug Label Information

Updated January 19, 2021

If you are a consumer or patient please visit this version.

  • DESCRIPTION
    Cesamet® (nabilone) is a synthetic cannabinoid for oral administration. Nabilone as a raw material occurs as a white to off-white polymorphic crystalline powder. In aqueous media, the solubility ...
  • CLINICAL PHARMACOLOGY
    Pharmacodynamics - Cesamet (nabilone) is an orally active synthetic cannabinoid which, like other cannabinoids, has complex effects on the central nervous system (CNS). It has been suggested ...
  • INDICATIONS AND USAGE
    Cesamet capsules are indicated for the treatment of the nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic ...
  • CONTRAINDICATIONS
    Cesamet is contraindicated in any patient who has a history of hypersensitivity to any cannabinoid.
  • WARNINGS
    • The effects of Cesamet may persist for a variable and unpredictable period of time following its oral administration. Adverse psychiatric reactions can persist for 48 to 72 hours following ...
  • PRECAUTIONS
    General - The benefit/risk ratio of Cesamet use should be carefully evaluated in patients with the following medical conditions because of individual variation in response and tolerance to the ...
  • ADVERSE REACTIONS
    Commonly Encountered Reactions: During controlled clinical trials of Cesamet, virtually all patients experienced at least one adverse reaction. The most commonly encountered events were ...
  • DRUG ABUSE AND DEPENDENCE
    Controlled Substance—Cesamet, a synthetic cannabinoid pharmacologically related to Cannabis sativa L. (Marijuana; (delta-9-THC) is a highly abusable substance. Cesamet is controlled under ...
  • OVERDOSAGE
    Signs and Symptoms—Signs and symptoms of overdosage are an extension of the psychotomimetic and physiologic effects of Cesamet. Treatment—To obtain up-to-date information about the treatment of ...
  • DOSAGE AND ADMINISTRATION
    The usual adult dosage is 1 or 2 mg 2 times a day. On the day of chemotherapy, the initial dose should be given 1 to 3 hours before the chemotherapeutic agent is administered. To minimize side ...
  • HOW SUPPLIED
    Cesamet® capsules (blue and white): 1 mg (bottles of 50 capsules) NDC 0187-1231-50. Capsules are imprinted with ICN on the blue cap and a four-digit code (3101) on the white body. Store at ...
  • PACKAGE/LABEL PRINCIPAL DISPLAY PANEL
    NDC 0187-1231-50 - Rx Only - Cesamet® CII - (nabilone) capsules    1 mg - 50 Capsules - Each capsule - contains 1 mg - nabilone - BAUSCH Health
  • INGREDIENTS AND APPEARANCE
    Product Information